Equities analysts expect ICU Medical, Incorporated (NASDAQ:ICUI) to announce earnings per share (EPS) of $2.18 for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for ICU Medical’s earnings, with the highest EPS estimate coming in at $2.23 and the lowest estimate coming in at $2.12. ICU Medical posted earnings per share of $2.26 in the same quarter last year, which suggests a negative year over year growth rate of 3.5%. The firm is expected to issue its next earnings report on Wednesday, May 8th.
According to Zacks, analysts expect that ICU Medical will report full-year earnings of $9.44 per share for the current fiscal year, with EPS estimates ranging from $9.43 to $9.45. For the next year, analysts expect that the business will report earnings of $10.27 per share. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that that provide coverage for ICU Medical.
ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Thursday, February 28th. The medical instruments supplier reported $1.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.56 by $0.22. The firm had revenue of $340.38 million for the quarter, compared to the consensus estimate of $314.60 million. ICU Medical had a return on equity of 13.31% and a net margin of 2.06%.
Several brokerages recently commented on ICUI. BidaskClub upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, February 20th. Zacks Investment Research raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $262.00 target price on the stock in a research note on Thursday, March 7th. TheStreet downgraded shares of ICU Medical from a “b-” rating to a “c+” rating in a research note on Tuesday, March 19th. Finally, Raymond James cut their target price on shares of ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating on the stock in a research note on Friday, March 1st. One research analyst has rated the stock with a sell rating, one has given a hold rating, one has given a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $281.00.
Shares of NASDAQ ICUI traded down $3.53 during mid-day trading on Friday, hitting $221.79. 282,744 shares of the stock were exchanged, compared to its average volume of 223,992. The firm has a market cap of $4.57 billion, a price-to-earnings ratio of 28.77 and a beta of 0.74. ICU Medical has a twelve month low of $210.94 and a twelve month high of $321.70.
In other news, Director Robert S. Swinney sold 1,500 shares of the company’s stock in a transaction that occurred on Monday, January 28th. The shares were sold at an average price of $242.19, for a total transaction of $363,285.00. Following the completion of the sale, the director now owns 19,540 shares of the company’s stock, valued at approximately $4,732,392.60. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Robert S. Swinney sold 1,464 shares of the company’s stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $234.65, for a total transaction of $343,527.60. Following the sale, the director now directly owns 16,576 shares of the company’s stock, valued at approximately $3,889,558.40. The disclosure for this sale can be found here. In the last quarter, insiders sold 8,470 shares of company stock worth $1,985,710. 11.40% of the stock is owned by company insiders.
Several institutional investors have recently modified their holdings of ICUI. Retirement Systems of Alabama boosted its holdings in ICU Medical by 0.4% during the fourth quarter. Retirement Systems of Alabama now owns 21,506 shares of the medical instruments supplier’s stock valued at $4,938,000 after acquiring an additional 93 shares during the period. Huntington National Bank increased its stake in shares of ICU Medical by 26.6% in the fourth quarter. Huntington National Bank now owns 443 shares of the medical instruments supplier’s stock worth $102,000 after purchasing an additional 93 shares in the last quarter. Advisory Services Network LLC increased its stake in shares of ICU Medical by 475.0% in the fourth quarter. Advisory Services Network LLC now owns 115 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 95 shares in the last quarter. New York State Teachers Retirement System increased its stake in shares of ICU Medical by 0.4% in the fourth quarter. New York State Teachers Retirement System now owns 24,739 shares of the medical instruments supplier’s stock worth $5,681,000 after purchasing an additional 100 shares in the last quarter. Finally, American International Group Inc. increased its stake in shares of ICU Medical by 0.4% in the fourth quarter. American International Group Inc. now owns 33,904 shares of the medical instruments supplier’s stock worth $7,785,000 after purchasing an additional 126 shares in the last quarter. 92.78% of the stock is owned by institutional investors.
About ICU Medical
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Featured Story: Initial Public Offering (IPO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.